Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.

Left ventricular remodeling is the process by which ventricular size, shape, and function are regulated by mechanical, neurohormonal, and genetic factors.1 2 Remodeling may be physiological and adaptive during normal growth or pathological due to myocardial infarction, cardiomyopathy, hypertension, or valvular heart disease (Figure 1⇓). This article will review postinfarction remodeling, pathophysiological mechanisms, and therapeutic intervention. Figure 1. Diagrammatic representation of the many factors involved in the pathophysiology of ventricular remodeling. ECM indicates extracellular matrix; RAAS, renin-angiotensin-aldosterone system; CO, cardiac output; SVR, systemic vascular resistance; LV, left ventricular; and AII, angiotensin II. ### Postinfarction Left Ventricular Remodeling The acute loss of myocardium results in an abrupt increase in loading conditions that induces a unique pattern of remodeling involving the infarcted border zone and remote noninfarcted myocardium. Myocyte necrosis and the resultant increase in load trigger a cascade of biochemical intracellular signaling processes that initiates and subsequently modulates reparative changes, which include dilatation, hypertrophy, and the formation of a discrete collagen scar. Ventricular remodeling may continue for weeks or months until the distending forces are counterbalanced by the tensile strength of the collagen scar. This balance is determined by the size, location, and transmurality of the infarct, the extent of myocardial stunning, the patency of the infarct-related artery, and local tropic factors.1 3 The myocardium consists of 3 integrated components: myocytes, extracellular matrix, and the capillary microcirculation that services the contractile unit assembly. Consideration of all 3 components provides important insights into the remodeling process and a rationale for future therapeutic strategies. The cardiomyocyte is terminally differentiated and develops tension by shortening. The extracellular matrix provides a stress-tolerant, viscoelastic scaffold consisting of type I and type III collagen that couples myocytes and maintains the spatial relations between the myofilaments and their capillary microcirculation.4 5 The collagen framework couples adjacent myocytes by intercellular struts that …

[1]  Therapy Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.

[2]  C. Delcayre,et al.  Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. , 1999, Hypertension.

[3]  S. Ball The Sympathetic Nervous System and Converting Enzyme Inhibition , 1989, Journal of cardiovascular pharmacology.

[4]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[5]  N. Sharpe,et al.  TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 1988, The Lancet.

[6]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[7]  B. Chaitman,et al.  Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial. , 1998, Circulation.

[8]  S. Kaul,et al.  Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. , 1989, Journal of the American College of Cardiology.

[9]  G. Hutchins,et al.  Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. , 1986, Journal of the American College of Cardiology.

[10]  D. Ganten,et al.  Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. , 1993, Journal of molecular and cellular cardiology.

[11]  H. White,et al.  Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. , 1994, Circulation.

[12]  G. Gamble,et al.  Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition , 1991, The Lancet.

[13]  H. Nagase Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.

[14]  GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. , 1994, Lancet.

[15]  I. Dixon,et al.  Expression of Gqα and PLC-β in Scar and Border Tissue in Heart Failure Due to Myocardial Infarction , 1998 .

[16]  K. Teo,et al.  Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). , 1999, Circulation.

[17]  G Olivetti,et al.  Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. , 1990, Circulation research.

[18]  F. Magrini,et al.  Converting-enzyme inhibition and coronary blood flow. , 1987, Circulation.

[19]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[20]  P. Anversa,et al.  Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. , 1985, The American journal of pathology.

[21]  P. Marino,et al.  Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. , 1989, Journal of the American College of Cardiology.

[22]  K. Weber,et al.  Effects of endothelins on collagen turnover in cardiac fibroblasts. , 1993, Cardiovascular research.

[23]  Raymond C. Schneider,et al.  ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.

[24]  G. Lamas,et al.  Activation of neurohumoral systems in postinfarction left ventricular dysfunction. , 1993, Journal of the American College of Cardiology.

[25]  V. Sukhatme,et al.  Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac alpha-myosin heavy chain gene. , 1991, The Journal of biological chemistry.

[26]  B. Bergman,et al.  Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. , 1994, The American journal of physiology.

[27]  Y. Zou,et al.  Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. , 1995, Circulation research.

[28]  K. Weber,et al.  Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. , 1994, Cardiovascular research.

[29]  J. Covell,et al.  Mechanisms of Augmented Segment Shortening in Nonischemic Areas during Acute Ischemia of the Canine Left Ventricle , 1985, Circulation research.

[30]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[31]  D. Gardner,et al.  N ATRIURETIC P EPTIDES , 1998 .

[32]  G. Lamas,et al.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. , 1988, The New England journal of medicine.

[33]  G. Lamas,et al.  Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. , 1995, Circulation.

[34]  A. Desmoulière,et al.  Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.

[35]  K. Weber,et al.  Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.

[36]  H. White,et al.  Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow. , 1999, Journal of the American College of Cardiology.

[37]  W. Grossman,et al.  Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. , 1988, Journal of the American College of Cardiology.

[38]  P. Brecher,et al.  Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. , 1992, The Journal of clinical investigation.

[39]  J. Sadoshima,et al.  The heterotrimeric G q protein‐coupled angiotensin II receptor activates p21 ras via the tyrosine kinase‐Shc‐Grb2‐Sos pathway in cardiac myocytes. , 1996, The EMBO journal.

[40]  J. Sadoshima,et al.  Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. , 1992, The Journal of biological chemistry.

[41]  P. Sugden,et al.  Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. , 1996, Circulation research.

[42]  K. Weber,et al.  Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin. , 1996, Cardiovascular research.

[43]  I. Dixon,et al.  Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. , 1998, Circulation.

[44]  M. Daemen,et al.  Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.

[45]  B. Jugdutt,et al.  Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. , 1988, Circulation.

[46]  T. Takano,et al.  [Left ventricular remodelling after acute myocardial infarction]. , 1994, Nihon rinsho. Japanese journal of clinical medicine.

[47]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico. GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction , 1994, The Lancet.

[48]  R. Doughty,et al.  Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease , 1997 .

[49]  A. Carayon,et al.  , Brigitte Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction : Effect of , 1999 .

[50]  R. Doughty,et al.  Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. , 1997, Journal of the American College of Cardiology.

[51]  K. Weber,et al.  Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.

[52]  J. Cleland,et al.  Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. , 1991, Journal of the American College of Cardiology.

[53]  J. Sadoshima,et al.  Critical Role of the AT1 Receptor Subtype , 2005 .

[54]  R. Jeremy,et al.  Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. , 1987, Journal of the American College of Cardiology.

[55]  J. Weiss,et al.  Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. , 1984, Journal of the American College of Cardiology.

[56]  P. Parker,et al.  Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. , 1994, The Journal of biological chemistry.

[57]  D. Mann,et al.  Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. , 1998, Circulation.

[58]  R. Senior,et al.  Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. , 1997, Circulation.